Solar cell production capacity more than doubled in 2010 says new report
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report.
By: Joe Walsh
The 131 page report states that the political will, public awareness and government incentives to support solar worldwide has changed the phase of the solar industry.
Europe, USA and Japan have been the primary sources of demand for the solar. The solar cell production capacity has more than doubled in the last one year or so. This trend is mainly driven by China. Governments in the US, Germany, China and Japan have played a major role in making solar industry one of the fastest growing energy technology industry in the world. China and Germany have emerged from the 2008-09 financial crises as the global leaders in solar.
The market for solar installation is still dominated by Germany, the United States and Japan. The Chinese market for solar remains small, hence most of the solar cells and modules are exported to other countries worldwide. The Chinese makers have slowly started catering to the domestic market too. The easy financing from the Chinese Government has helped many manufacturers to expand into the solar supply chain becoming vertically integrated companies. Overproduction in China has brought down the prices of solar cells worldwide. The low prices of solar cells have made manufacturers in other parts of the world difficult to complete. Overall, the government in China has played a pivotal role in increasing the solar wafer and cell production capacity within China and lowering the prices.
The report “Worldwide Solar Cell Manufacturing Facilities and Production Capacity 2010-2015” is available from Report Buyer at:
Reportbuyer Product Code: FUJ00078
Report Buyer http://www.reportbuyer.com/
# # #
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare.